Does UPADACITINIB Cause Dyspnoea? 1,219 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,219 reports of Dyspnoea have been filed in association with UPADACITINIB (Rinvoq). This represents 1.9% of all adverse event reports for UPADACITINIB.
1,219
Reports of Dyspnoea with UPADACITINIB
1.9%
of all UPADACITINIB reports
118
Deaths
570
Hospitalizations
How Dangerous Is Dyspnoea From UPADACITINIB?
Of the 1,219 reports, 118 (9.7%) resulted in death, 570 (46.8%) required hospitalization, and 113 (9.3%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 1,219 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which UPADACITINIB Alternatives Have Lower Dyspnoea Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL